Entrada Therapeutics, Inc. (TRDA)

Last Three Months

29-Jan-24 -- 28-Apr-24

Time Period:

Three Months
|
Year

$25.68K Net Amount

Buy:	$25.68K	$12.66 - $12.66
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

10

0

5

+1

0

+2

0

+3

Two Year Chart

29-Apr-22 -- 28-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
19-Mar-24 4:33 PM View:	15-Mar-24 Option Exercise $18.90K	Wentworth Kory James Chief Financial Officer		Entrada Therapeutics, Inc. - TRDA	68% 49.57K to 83.17K	0	0	--	--	Show Txns Hide Txns

05-Mar-24 7:44 PM View:	05-Mar-24 Payment of Exercise ($18.48K)	Sethuraman Natarajan Chief Scientific Officer		Entrada Therapeutics, Inc. - TRDA	25% 167.2K to 209.03K	0	0	--	--	Show Txns Hide Txns

10-Apr-24 4:35 PM View:	08-Apr-24 Purchase $35.29K	Kim Peter S Director		Entrada Therapeutics, Inc. - TRDA	34% 47.04K to 62.94K	$25.68K 4%	0	$12.66 - $12.66	--	Show Txns Hide Txns

05-Mar-24 7:48 PM View:	05-Mar-24 Payment of Exercise ($62.00K)	Doshi Dipal CEO Director		Entrada Therapeutics, Inc. - TRDA	39% 244.28K to 340.38K	0	0	--	--	Show Txns Hide Txns

08-Mar-24 4:34 PM View:	06-Mar-24 Private Sale (Planned) ($22.50K)	Dowden Nathan J President & COO		Entrada Therapeutics, Inc. - TRDA	185% 48.17K to 137.2K	0	0	--	--	Show Txns Hide Txns